Organic, Medicinal and Pharmaceutical Chemist
Posts tagged Health
CHEM MED CHEM Article: Adenosine A2A Receptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson’s Disease
Jun 24th
Adenosine A2A Receptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson’s Disease
Rosaria Volpini, Prof., Diego Dal Ben, Dr., Catia Lambertucci, Dr., Gabriella Marucci, Prof. Dr., Ram Chandra Mishra, Dr., Anna Teresa Ramadori, Dr., Karl-Norbert Klotz, Prof., Maria Letizia Trincavelli, Dr. , Claudia Martini, Prof., Gloria Cristalli, Prof.
Abstract:
A new series of 8-substituted 9-ethyladenine derivatives has been synthesized and tested at rat and human adenosine receptors. Binding data demonstrates that some compounds could represent new tools suitable for in vivo studies in rat models of Parkinson’s disease and for the design of new molecules with improved affinity and selectivity at human AA2AR.
Clinical evidence has demonstrated that AA2AR antagonists could be an alternative approach to the treatment of Parkinson’s disease. Recently, three 9-ethyladenine derivatives bearing a bromine atom, an ethoxy group, and a furyl ring, respectively, in the 8-position have been reported to ameliorate motor deficits in rat Parkinson’s disease models, suggesting a potential therapeutic role for these compounds. Starting from these observations, a new series of 9-ethyladenine derivatives, bearing different substituents such as halogens, alkoxy groups, aromatic and heteroaromatic rings in the 8-position, were synthesized. Radioligand binding assays demonstrated that some of the new compounds bind rat AA2AR with higher affinity than the previously reported congeners and that there is a good correlation between binding to rat and human receptors. Hence, the new molecules could represent new tools suitable for the in vivo studies in rat models of Parkinson’s disease. Finally, a molecular docking analysis of the compounds was performed using a homology model of rat AA2AR, built using the human crystal structure as the template, and results are in agreement with the binding data.
Abstract | References | Full Text: HTML, PDF (Size: 518K) | Related Articles | Citation Tracking
Indian Turmeric’s (हल्दी) healing secret, finally revealed?
Apr 23rd

- Image via Wikipedia

Copyright 2009 American Chemical Society
In the study, Ayyalusamy Ramamoorthy and colleagues point out that turmeric has been used for centuries in folk medicine to treat wounds, infections, and other health problems. Although modern scientific research on the spice has burgeoned in recent years, scientists until now did not know exactly how curcumin works inside the body.
http://www.medicalnewstoday.com/articles/146512.php
Medical News Today (U.K.: 1.8 million monthly unique users)
Related articles by Zemanta
- ‘Holy powder’ ingredient makes membranes behave for better health (scienceblog.com)
- Antioxidants help your body do a better job (thestar.com)
- News From The American Chemical Society , April 8, 2009 (medicalnewstoday.com)
- Turmeric The Miracle Spice (findmeacure.com)
The anti-cancer activity of Noscapine: A Review
Jan 30th

- Image via Wikipedia
Noscapine is an isoqiunoline alkaloid found in opium latex. Unlike most other alkaloids obtained from opium latex, noscapine is not sedative and has been used as antitussive drug in various countries. Recently, it has been introduced as an anti-mitotic agent. This drug can be used orally.When the resistance to other anti-cancer drugs such as paclitaxel menifests, noscapine might be effective. Therefore, noscapine and its analogs have great potential as novel anti-cancer agents.
Related articles
- Study Shows That A Cough Medicine Ingredient Could Effectively Treat Prostate Cancer (lockergnome.com)
- Tackling the Afghan heroin problem one pomegranate at a time (inquisitr.com)
- Neoadjuvant Herceptin Improves Event-free Survival in Locally Advanced Breast Cancer According to the international Phase III NOAH trial, the addition of Herceptin (trastuzumab) to neoadjuvant chemotherapy significantly improves event-free survival com (oncoblog.com)
- RAD001 Shows Promise In Tough-to-Treat Breast Cancer Patients (medicalnewstoday.com)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=de23abc6-28e4-432c-bcd0-34a5f001ac89)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=fc7e79f0-0381-433b-9900-7d1972732cdb)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=bc322b3b-7df0-4919-ae59-29ab370e9ba8)